Protective effect of bupropion on morphine tolerance and dependence in mice

Methods and Findings in Experimental and Clinical Pharmacology

Volumn 26, Issue 8, 2004, Pages 623-626

  Joshi, D ^a   Singh, A ^a   Naidu, P S ^a   Kulkarni, S K ^a  

^a PANJAB UNIVERSITY   (India)

Author keywords

Bupropion; Morphine dependence; Morphine tolerance; Naloxone; Tail flick latency; Withdrawal jump

Indexed keywords

AMFEBUTAMONE; MORPHINE; NALOXONE;

ANALGESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CHRONIC DRUG ADMINISTRATION; CONTROLLED STUDY; DRUG TOLERANCE; FEMALE; MALE; MORPHINE ADDICTION; MOUSE; NONHUMAN; PATHOGENESIS; TAIL FLICK TEST; WITHDRAWAL SYNDROME;

ANALGESICS, OPIOID; ANIMALS; BUPROPION; DOPAMINE UPTAKE INHIBITORS; DRUG COMBINATIONS; DRUG INTERACTIONS; DRUG TOLERANCE; FEMALE; MALE; MICE; MORPHINE; MORPHINE DEPENDENCE; PAIN THRESHOLD;

EID: 9644275387     PISSN: 03790355     EISSN: None     Source Type: Journal    
DOI: 10.1358/mf.2004.26.8.863727     Document Type: Article

References (23)

1. Bhargava, H.N. Diversity of agents that modify opioid tolerance, physical dependence, abstinence syndrome and self-administrative behaviour. Pharmacol Rev 1994, 46: 293-324.
2. Kulkarni, S.K., Verma, A. Prevention of development of tolerance and dependence to opiate in mice by BR-I6A (Mental). Ind J Exp Biol 1992, 30: 885-8.
3. Blasig, J., Herz, A., Reinhold, K., Zieglgansberger, S. Development of physical dependence on morphine in respect to time and dosage and quantification of the precipitated withdrawal syndrome in rats. Psychopharmacologia 1973, 33: 19-38.
4. Dambisya, Y.M., Lee, T.L. Role of nitric oxide in the induction and expression of morphine tolerance and dependence in mice. Br J Pharmacol 1996, 117: 914-8.
5. Paul, M.A., Gray, G., Kenny, G., Lange, M. The impact of bupropion on psychomotorperformance. Aviat Space Environ Med 2002, 73(11): 1094-99.
6. th Annual Meeting of the American Psychiatric Association. Washington, DC: American Psychiatric Assoc 1994, 199-200.
7. Hurt, R.D., Sachs, D.P.L., Glover, E.D. et al. A comparison of the sustained-release bupropion and placebo for smoking cessation. N Engl J Med 1997, 337: 1195-202.
8. Jorenby, D.E., Leischow, S.J., Nides, M.A. et al. A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation. N Engl J Med 1999, 340: 685-91.
9. Shiffman, S., Johnston, J.A., Khayrallah, M. et al. The effect of bupropion on nicotine craving and withdrawal. Psychopharmacology 2000, 148: 33-40.
10. Holm, K.J., Spencer, C.M. Bupropion: A review of its use in the management of smoking cessation. Drugs 2000, 59(4): 1007-24.
11. Pipe, A.L., Reid, R., Boucher, K. Sustained-release bupropion as an aid to smoking cessation. Today's Therapeutic Trends 2000, 18: 52-70.
12. Reddy, D.S., Kulkarni, S.K. Chronic neurosteroid treatment prevents development of morphine tolerance and attenuates abstinence behavior in mice. Eur J Pharmacol 1997, 337: 19-25.
13. Verma, A., Kulkarni, S.K. Role of DI/D2 dopamine and N-Methyl-D-Aspartate (NMDA) receptors in morphine tolerance and dependence in mice. Neuropsychopharmacol 1995, 5: 81-7.
14. Singh, A., Naidu, P.S., Kulkarni, S.K. Quercetin, a bioflavonoid, reverses development of tolerance and dependence to morphine. Drug Dev Res 2002, 51: 1-6.
15. Kulkarni, S.K., Ninan, I. Inhibition of morphine tolerance and dependence by Withania somnifera in mice. J Ethnopharmacol 1997, 57: 213-7.
16. Ninan, I., Kulkarni, S.K. Ketanserin reverses dozocilpine suppression of morphine dependence but not tolerance in mice. Brain Res 2000, 876: 215-9.
17. Raghavendra, V., Kulkarni, S.K. Possible mechanisms of action in melatonin reversal of morphine tolerance and dependence in mice. Eur J Pharmacol 2000, 409: 279-89.
18. Vaccarino, A.L., Kastin, A.J. Endogenous opiates: 2000. Peptides 2001, 22: 2257-328.
19. Cuellar, B., Fernandez, A.P., Lizasoain, I. et al. Up-regulation of neuronal NO synthase immunoreactivity in opiate dependence and withdrawal. Psychopharmcology 2000, 148: 66-73.
20. Powell, K.J., Hosokawa, A., Bell, A. et al. Comparative effects of cyclo-oxygenase and nitric oxide synthase inhibition on the development and reversal of spinal opioid tolerance. Br J Pharmacol 1999, 127: 631-44.
21. Balfour, D.J.K. The pharmacology underlying pharmacotherapy for tobacco dependence: A focus on bupropion. Int J Clin Pract 2001, 55: 53-7.
22. Fryer, J.D., Lukas, R.J. Noncompetitive functional inhibition at diverse, human nicotinic acetylcholine receptor subtypes by bupropion, phencyclidine, and ibogaine. J Pharmacol Exp Ther 1999, 288: 88-92.
23. Balfour, D.J.K. The neurobiology of tobacco dependence: A commentary. Respiration 2002, 69: 7-11.